123 related articles for article (PubMed ID: 9627179)
1. Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma.
Würl P; Meye A; Berger D; Lautenschläger C; Bache M; Holzhausen HJ; Schmidt H; Dralle H; Rath FW; Taubert H
Langenbecks Arch Surg; 1998 Mar; 383(1):99-103. PubMed ID: 9627179
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
3. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
5. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas.
Würl P; Meye A; Lautenschläger C; Schmidt H; Bache M; Kalthoff H; Schönfelder M; Rath FW; Taubert H
Cancer Lett; 1999 May; 139(2):159-65. PubMed ID: 10395173
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
Würl P; Meye A; Berger D; Bache M; Lautenschläger C; Schmidt H; Kalthoff H; Rath FW; Taubert H
Diagn Mol Pathol; 1997 Oct; 6(5):249-54. PubMed ID: 9458382
[TBL] [Abstract][Full Text] [Related]
8. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
[TBL] [Abstract][Full Text] [Related]
9. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O
Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207
[TBL] [Abstract][Full Text] [Related]
10. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
Taubert H; Koehler T; Meye A; Bartel F; Lautenschläger C; Borchert S; Bache M; Schmidt H; Würl P
Mol Med; 2000 Jan; 6(1):50-9. PubMed ID: 10803408
[TBL] [Abstract][Full Text] [Related]
11. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
[TBL] [Abstract][Full Text] [Related]
12. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
Wunder JS; Czitrom AA; Kandel R; Andrulis IL
J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
[TBL] [Abstract][Full Text] [Related]
13. Molecular biological aspects of soft tissue tumors.
Triche TJ
Curr Top Pathol; 1995; 89():47-72. PubMed ID: 7882720
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
[TBL] [Abstract][Full Text] [Related]
15. p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.
Gerdes B; Ramaswamy A; Ziegler A; Lang SA; Kersting M; Baumann R; Wild A; Moll R; Rothmund M; Bartsch DK
Ann Surg; 2002 Jan; 235(1):51-9. PubMed ID: 11753042
[TBL] [Abstract][Full Text] [Related]
16. Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene.
Meye A; Würl P; Bache M; Bartel F; Grünbaum U; Mansa-ard J; Schmidt H; Taubert H
Cancer Lett; 2000 Feb; 149(1-2):181-8. PubMed ID: 10737722
[TBL] [Abstract][Full Text] [Related]
17. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
18. MDM2 gene amplification correlates with ring chromosome in soft tissue tumors.
Nilbert M; Rydholm A; Willén H; Mitelman F; Mandahl N
Genes Chromosomes Cancer; 1994 Apr; 9(4):261-5. PubMed ID: 7519048
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
Skomedal H; Kristensen GB; Lie AK; Holm R
Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
